OBJECTIVE: To reassess the predictive value of detecting sperm cells in men with AZFb or AZFb-c deletions. DESIGN: Retrospective analysis of previously reported men with AZFb or AZFb-c deletions and the addition of six new cases. SETTING: Fertility institution. PATIENT(S): Men with both sequence tagged site marker identification and testicular cytology/histology findings. INTERVENTION(S): Systematic review of reported men with microdeletions that included eligibility, data extraction and analysis. MAIN OUTCOME MEASURE(S): Availability of sperm cells for intracytoplasmic sperm injection (ICSI) in men with AZFb/AZFb-c microdeletions. RESULT(S): The average prevalences reported for AZFb, AZFb-c, partial AZFb, and partial AZFb-c in azoospermic men were 0.9%±0.07%, 2.7%±0.93%, 1.23%±0.9%, and 1%±0.6%, respectively. Sperm cells were identified in 7% and 3% of the 28 and 71 men with complete AZFb and AZFb-c and in 57% and 43% of the 14 and 7 men with partial AZFb and AZFb-c deletions, respectively. The likelihood of finding sperm cells in men with complete versus partial AZFb and AZFb-c deletions was significantly lower. As yet, no clinical or chemical pregnancy after ICSI in cases with complete AZFb/b-c microdeletions has been reported. CONCLUSION(S): Determining the extent of AZFb or AZFb-c deletions is critical considering the frequency and the reasonable prospect of finding sperm cells in partial AZFb/AZFb-c deletions. Referring men with complete AZFb/b-c microdeletions to testicular sperm extraction/ICSI programs should be revaluated.
OBJECTIVE: To reassess the predictive value of detecting sperm cells in men with AZFb or AZFb-c deletions. DESIGN: Retrospective analysis of previously reported men with AZFb or AZFb-c deletions and the addition of six new cases. SETTING: Fertility institution. PATIENT(S): Men with both sequence tagged site marker identification and testicular cytology/histology findings. INTERVENTION(S): Systematic review of reported men with microdeletions that included eligibility, data extraction and analysis. MAIN OUTCOME MEASURE(S): Availability of sperm cells for intracytoplasmic sperm injection (ICSI) in men with AZFb/AZFb-c microdeletions. RESULT(S): The average prevalences reported for AZFb, AZFb-c, partial AZFb, and partial AZFb-c in azoospermic men were 0.9%±0.07%, 2.7%±0.93%, 1.23%±0.9%, and 1%±0.6%, respectively. Sperm cells were identified in 7% and 3% of the 28 and 71 men with complete AZFb and AZFb-c and in 57% and 43% of the 14 and 7 men with partial AZFb and AZFb-c deletions, respectively. The likelihood of finding sperm cells in men with complete versus partial AZFb and AZFb-c deletions was significantly lower. As yet, no clinical or chemical pregnancy after ICSI in cases with complete AZFb/b-c microdeletions has been reported. CONCLUSION(S): Determining the extent of AZFb or AZFb-c deletions is critical considering the frequency and the reasonable prospect of finding sperm cells in partial AZFb/AZFb-c deletions. Referring men with complete AZFb/b-c microdeletions to testicular sperm extraction/ICSI programs should be revaluated.
Authors: Peter J Stahl; Anna N Mielnik; Christopher E Barbieri; Peter N Schlegel; Darius A Paduch Journal: Asian J Androl Date: 2012-07-23 Impact factor: 3.285
Authors: Mariano Mascarenhas; Sumi Thomas; Mohan S Kamath; Ramya Ramalingam; Ann Marie Kongari; S Yuvarani; Vivi M Srivastava; Korula George Journal: J Hum Reprod Sci Date: 2016 Jul-Sep
Authors: Ki Eun Kim; Ye Jin Kim; Mo Kyoung Jung; Hyun-Wook Chae; Ah Reum Kwon; Woo Jung Lee; Duk-Hee Kim; Ho-Seong Kim Journal: Ann Pediatr Endocrinol Metab Date: 2017-12-31
Authors: Gleice Cristina Dos Santos Godoy; Bianca Borsatto Galera; Claudinéia Araujo; Jacklyne Silva Barbosa; Max Fernando de Pinho; Marcial Francis Galera; Sebastião Freitas de Medeiros Journal: Clin Med Insights Reprod Health Date: 2014-08-11